Mohamed I Elsaid
Overview
Explore the profile of Mohamed I Elsaid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enserro D, Gunn H, Elsaid M, Duan F, Pugh S
J Natl Cancer Inst Monogr
. 2025 Feb;
2025(68):49-55.
PMID: 39989045
Prevention trials in oncology are some of the most important cancer clinical trials that can be designed, implemented, analyzed, and interpreted. They are pivotal in the goal of stopping the...
2.
Unger J, Mazza G, Elsaid M, Duan F, Dressler E, Snavely A, et al.
J Natl Cancer Inst Monogr
. 2025 Feb;
2025(68):3-9.
PMID: 39989044
Interpreting cancer clinical trial results often depends on addressing issues of multiplicity. When testing multiple hypotheses, unreliable findings can occur by chance due to the inflation of the type I...
3.
Guerrini C, Robinson J, Elsaid M, Brooks W, Levchenko A, Fullerton S, et al.
Forensic Sci Int
. 2025 Jan;
367:112372.
PMID: 39874882
In 2018, after law enforcement announced it had used a technique called forensic investigative genetic genealogy (FIGG) to identify the Golden State Killer, we conducted a U.S. general population survey...
4.
Greteman B, Cole A, Charlton M, Shannon J, Kepka D, Paskett E, et al.
BMC Cancer
. 2025 Jan;
25(1):50.
PMID: 39789488
Background: The COVID-19 pandemic involved business closures (e.g., gyms), social distancing policies, and prolonged stressful situations that may have impacted engagement in health behaviors. Our study assessed changes in cancer-related...
5.
Zitu M, Gatti-Mays M, Johnson K, Zhang S, Shendre A, Elsaid M, et al.
Pragmat Obs Res
. 2024 Dec;
15:243-252.
PMID: 39720010
Purpose: We developed an artificial intelligence (AI) model to detect immunotherapy -related adverse events (irAEs) from clinical narratives of electronic health records (EHRs) at the patient level. Patients And Methods:...
6.
Jiang J, Bouquet E, Kweon Y, Elsaid M, Diaz D, Conteh L, et al.
Clin Res Hepatol Gastroenterol
. 2024 Nov;
48(10):102485.
PMID: 39489339
Background: The Ohio Opportunity Index (OOI) is a multidimensional metric used to quantify neighborhood-level resources to access a wide array of factors that influence health. This study examined the relationship...
7.
Crossnohere N, Campoamor N, Negash R, Wood M, Studts J, Elsaid M, et al.
Cancer Control
. 2024 Oct;
31:10732748241291609.
PMID: 39397323
Background: Multi-cancer early detection tests (MCEDs) have the potential to identify over 50 types of cancer from a blood sample, possibly transforming cancer screening paradigms. Studies on the safety and...
8.
Elsaid M, Simon Meara A, Owen D
J Clin Oncol
. 2024 Oct;
42(35):4119-4122.
PMID: 39356977
No abstract available.
9.
10.
Chen J, Handley D, Elsaid M, Fisher J, Plascak J, Anderson L, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2427755.
PMID: 39207755
Importance: Patients with breast cancer residing in socioeconomically disadvantaged communities often face poorer outcomes (eg, mortality) compared with individuals living in neighborhoods without persistent poverty. Objective: To examine persistent neighborhood...